Confluence Investment Management LLC Sells 10,362 Shares of The Clorox Company (NYSE:CLX)

Confluence Investment Management LLC cut its position in The Clorox Company (NYSE:CLX - Free Report) by 1.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 871,235 shares of the company's stock after selling 10,362 shares during the quarter. Clorox makes up about 1.9% of Confluence Investment Management LLC's holdings, making the stock its 14th biggest position. Confluence Investment Management LLC owned about 0.70% of Clorox worth $141,933,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of CLX. First Foundation Advisors bought a new position in shares of Clorox in the first quarter worth about $31,000. Innealta Capital LLC acquired a new stake in Clorox in the 2nd quarter valued at approximately $30,000. Trifecta Capital Advisors LLC increased its position in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock worth $30,000 after buying an additional 130 shares during the period. Quarry LP lifted its holdings in shares of Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after buying an additional 114 shares during the last quarter. Finally, Family Firm Inc. bought a new stake in shares of Clorox in the second quarter valued at approximately $31,000. Institutional investors own 78.53% of the company's stock.

Clorox Trading Up 1.5 %

Shares of CLX traded up $2.43 during trading hours on Friday, hitting $165.20. 1,276,243 shares of the stock traded hands, compared to its average volume of 1,244,660. The business has a fifty day moving average of $162.14 and a 200-day moving average of $146.83. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.45 billion, a PE ratio of 57.56, a price-to-earnings-growth ratio of 3.02 and a beta of 0.41. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $169.09.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company's revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.49 EPS. Analysts expect that The Clorox Company will post 6.81 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.95%. The ex-dividend date was Wednesday, October 23rd. Clorox's dividend payout ratio (DPR) is currently 170.04%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CLX shares. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research report on Monday, October 14th. Citigroup increased their target price on shares of Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Barclays lifted their target price on Clorox from $137.00 to $139.00 and gave the stock an "underweight" rating in a research report on Friday, November 1st. Deutsche Bank Aktiengesellschaft upped their price target on Clorox from $144.00 to $151.00 and gave the company a "hold" rating in a report on Friday, August 2nd. Finally, JPMorgan Chase & Co. lifted their price objective on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $155.00.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the company's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.57% of the stock is owned by corporate insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.